Abstract
The current COVID-19 pandemic has highlighted global supply chain shortcomings in the US hospital delivery system, most notably personal protective equipment (PPE) and COVID-19 is found on these masks ∼7 days. Recent work from our group has shown two promising disinfection methods for N95 facial masks, dry heat (hot air (75 °C, 30 min) and UVGI which is UVGI 254 nm, 8W, 30 min. Using N95 five models of N95 masks from three different manufacturers we determined the following: 1) Hot air treated N95 masks applied over 5 cycles did not degrade the fit of masks (1.5% change in fit factor, p = .67), 2) UVGI treated N95 masks applied over 10 cycles were significantly degraded in fit and did not pass quantitative fit testing using OSHA testing protocols on a human model (−77.4% change in fit factor, p = .0002).
NOTE We would like to share our results with the community as soon as possible. Be mindful that this report is a pilot study and a work in progress. We will have more results in the coming days and weeks.
We recommend that hospital policy and procedures be respected and adhered to. Do not use anything in your home to disinfect contaminated equipment. Please do not heat your masks in a home oven!
Competing Interest Statement
Steve Chu and Yi Cui are the co-founders of 4C Air and owns the shares of 4C Air. Steve Chu and Yi Cui reports non-financial support from 4C Air; In addition, Steve Chu and Yi Cui has a patent PCT /US2015/065608 licensed to 4C Air. 4C Air tested face masks from several manufacturers that include 4C Air's masks and those of other manufacturers.
Funding Statement
The work was not supported by any external funding sources.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available upon request to the corresponding author
